The Global Health Body Sounds Warning Over Acute Shortage of Obesity Medications
Under a tenth of people that would benefit from weight-loss injections including Wegovy have access to them, caution the global health agency as it releases its first guidance on the therapies.
With more than one billion individuals worldwide currently classified as obese, it is calling for increased and just availability to GLP-1 medication.
According to projections, more than two billion could be obese by 2030 if no action is taken.
"The latest guidelines recognises that obesity is a lifelong illness that can be treated with thorough and ongoing support," stated the agency's head Tedros Adhanom Ghebreyesus.
High costs, limited production capacity, and logistical bottlenecks are significant hurdles to widespread availability to the injections that can assist patients in reducing considerable body mass, says the organization.
Skinny Jab Scarcity
Despite the present most favorable scenario, the production of such drugs would only suffice for approximately 100 million people – under 10% of the global need, as stated by the health organization.
The recommendation calls on countries and companies to expand availability, by approaches including patent sharing.
The intellectual property rights on the active ingredient – the primary ingredient of Novo Nordisk's Wegovy – is due to expire in multiple nations in 2026.
How Weight-Loss Injections Operate
GLP-1 drugs mimick a natural hormone to reduce digestion speed, suppress the appetite and boost the sense of being full so users consume fewer calories.
People commonly start to lose weight within a few weeks of beginning the once-weekly jabs.
Evidence indicates people may regain a significant portion a year later of stopping the treatment, as their usual hunger come back.
To be carrying excess weight raises your risk for developing health problems, such as type 2 diabetes, cardiovascular issues, brain attack, and some malignancies.
Obesity concerns individuals in all nations and was responsible for over three and a half million deaths worldwide in 2024, as per the WHO.
